Langaware predicts neurodegenerative diseases by detecting and monitoring digital biomarkers based on language and speech.
Langaware has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in October 2023.
Langaware's investors include Eleven Ventures, Metavallon VC, Georgios Papadopoulos.
Langaware is headquartered in Menlo Park, United States.
Langaware predicts neurodegenerative diseases by detecting and monitoring digital biomarkers based on language and speech.
Langaware is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Langaware — Funding & Investors." VCBacked, October 4, 2023, https://www.vcbacked.co/company/langaware. Accessed September 15, 2026.
VCBacked. (2023). Langaware — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/langaware
{{cite web |title=Langaware — Funding & Investors |url=https://www.vcbacked.co/company/langaware |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated